330 related articles for article (PubMed ID: 19440886)
1. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
[TBL] [Abstract][Full Text] [Related]
7. Are psychological treatments for depression in primary care cost-effective?
Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
[TBL] [Abstract][Full Text] [Related]
8. Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial.
Schoenbaum M; Sherbourne C; Wells K
J Affect Disord; 2005 Aug; 87(2-3):319-25. PubMed ID: 16005520
[TBL] [Abstract][Full Text] [Related]
9. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK.
Koeser L; Donisi V; Goldberg DP; McCrone P
Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of an intervention to prevent depression in at-risk teens.
Lynch FL; Hornbrook M; Clarke GN; Perrin N; Polen MR; O'Connor E; Dickerson J
Arch Gen Psychiatry; 2005 Nov; 62(11):1241-8. PubMed ID: 16275811
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacoeconomic evaluation of combination therapy with dutasteride and α1 blocker for treatment of benign prostatic hyperplasia in Japan].
Takayama T; Arakawa I; Kakihara H; Tachibana K; Ozono S
Hinyokika Kiyo; 2012 Feb; 58(2):61-9. PubMed ID: 22450830
[TBL] [Abstract][Full Text] [Related]
12. Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Diaz-Montes TP; Gardner GJ; Giuntoli RL; Meisner BC; Frick KD; Armstrong DK
Cancer; 2007 Apr; 109(8):1513-22. PubMed ID: 17354232
[TBL] [Abstract][Full Text] [Related]
13. The burden of major depression avoidable by longer-term treatment strategies.
Vos T; Haby MM; Barendregt JJ; Kruijshaar M; Corry J; Andrews G
Arch Gen Psychiatry; 2004 Nov; 61(11):1097-103. PubMed ID: 15520357
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.
Wagner M; Goetghebeur M; Merikle E; Pandya A; Chu P; Taylor DC
Can J Clin Pharmacol; 2009; 16(2):e331-45. PubMed ID: 19531812
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant occupational therapy for work-related major depression works: randomized trial including economic evaluation.
Schene AH; Koeter MW; Kikkert MJ; Swinkels JA; McCrone P
Psychol Med; 2007 Mar; 37(3):351-62. PubMed ID: 17112401
[TBL] [Abstract][Full Text] [Related]
17. The human cost of not achieving full remission in depression.
McIntyre RS; O'Donovan C
Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):10S-16S. PubMed ID: 15147032
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: a randomized clinical trial.
Sava FA; Yates BT; Lupu V; Szentagotai A; David D
J Clin Psychol; 2009 Jan; 65(1):36-52. PubMed ID: 19051275
[TBL] [Abstract][Full Text] [Related]
19. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression.
Kozel FA; George MS; Simpson KN
CNS Spectr; 2004 Jun; 9(6):476-82. PubMed ID: 15162090
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.
Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA
J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
